Elevation Oncology (ELEV) director Carruthers received 31,238 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
R Michael Carruthers (director at Elevation Oncology Inc., ELEV) reported that they received 31,238 Stock Option (Right to Buy) on Jun 16, 2023.
- Reporting person
- Carruthers R Michael
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 16, 2023 | Grant or award (A) | Stock Option (Right to Buy)On 31,238 Common Stock1 | +31,238 | - | - | 31,238 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 31,238 direct
Footnotes from the filing
- 1. The stock option vests as to 100% of the total shares on the one-year anniversary of the grant date, subject to the Reporting Person's provision of service to the Issuer on such vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Carruthers report in this ELEV Form 4?
R Michael Carruthers (director at Elevation Oncology Inc., ELEV) reported that they received 31,238 Stock Option (Right to Buy) on Jun 16, 2023.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for ELEV
Earlier insider filings at ELEV
- Jun 21, 2023SEC Form 4 filed by Aisling Capital Iv, Lp
- Jun 21, 2023SEC Form 4 filed by Ferra Joseph J Jr
- Mar 20, 2023SEC Form 4 filed by Elevation Oncology Inc.
- Feb 17, 2023SEC Form 4 filed by Jansen Valerie Malyvanh
- Feb 17, 2023SEC Form 4 filed by Dornan David
Quantisnow market dataNASDAQ
ELEV
Elevation Oncology Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2021
Get push alerts for ELEV
Full ELEV profile on Quantisnow Follow ELEV and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time